COMMUNIQUÉS West-GlobeNewswire

MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the “Company”) (Nasdaq: GBT ) today announced the appointment of David L. Johnson as chief commercial officer, [...]
3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer
06/03/2018
TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS "), a personalized medicine company with a proprietary software platform based on the three- [...]
Phase 1 Clinical Data Demonstrating CLR 124 Uptake in Brain Tumors Accepted for Oral Presentation at the 12th World Congress of the World Federation of Nuclear Medicine and Biology
06/03/2018
MADISON, Wis., March 06, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma
06/03/2018
EXTON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
HempAmericana Announces Purchase of Next Generation CBD Purification System
06/03/2018
NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is proud to announce the Company’s purchase of a Gilson CPC 1000 centrifugal partition [...]
Emerald Health Therapeutics Grants Options to Executive
06/03/2018
VICTORIA, British Columbia, March 06, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) issued 120,000 incentive stock options to Paul Dillman, VP Marketing and Sales. The [...]
KemPharm to Present at Upcoming Investor Conferences
06/03/2018
Presentations to Highlight Corporate and Clinical Progress CORALVILLE, Iowa, March 06, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a specialty pharmaceutical company focused on the discovery and development [...]
Flexion Therapeutics Presents Clinical Data at AAOS 2018 Annual Meeting and the American Pain Society Annual Scientific Meeting
06/03/2018
Post-hoc analysis demonstrates potential of ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension) to provide effective pain relief regardless of prior intra-articular corticosteroid use Effects of [...]
Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences
06/03/2018
SOLANA BEACH, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave [...]
Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference
06/03/2018
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Marinus Pharmaceuticals Provides Business Update and 2017 Financial Results
06/03/2018
RADNOR, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]
Protalix BioTherapeutics Reports 2017 Full Year Results and Provides Corporate Update
06/03/2018
Enrollment in all Fabry Trials is ongoing in over Forty Active Sites Current Cash is Projected to Fund the Company through Clinical Trial Read-Outs and into 2020 CARMIEL, Israel, March 06, 2018 (GLOBE NEWSWIRE) -- [...]
Keryx Biopharmaceuticals to Webcast its Presentation at the Cowen 38th Annual Healthcare Conference on March 12, 2018
06/03/2018
BOSTON, March 06, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will [...]
Otonomy to Present at Cowen and Company Health Care Conference
06/03/2018
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber, Ph.D., [...]
Strongbridge Biopharma plc to Present at the Cowen and Company 38th Annual Healthcare Conference and the Oppenheimer 28th Annual Healthcare Conference
06/03/2018
DUBLIN, Ireland and TREVOSE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
BioCorRx to Exhibit at the Addiction Executives Industry Summit in Ponte Verde Beach, FL
06/03/2018
ANAHEIM, CA, March 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the [...]
Clearside Biomedical Provides Update on Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion
06/03/2018
ALPHARETTA, Ga., March 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today [...]
Genetic Technologies Limited: Project Shivom Strategic Alliance
06/03/2018
MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”, “ GTG ”) a diversified molecular diagnostics company; provider of BREVAGen plus ®, a first-in [...]

Pages